pev301
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT00513669)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pev301
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00513669 | Phase 1 | Jan 1, 2008 | Mymetics Corporation, Pevion Biotech Ltd, University of Basel |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mymetics Corporation | For profit | 1 | 0 | 1 | 2008 |
| Pevion Biotech Ltd | For profit | 1 | 0 | 1 | 2008 |
| University of Basel | Academic/Hospital | 1 | 1 | 1 | 2008 |
3 organizations
Page 1 / 1